ABUS vs AON · P/E 5.4, rev $6.2M vs P/E 31, rev $17.18B
Arbutus Biopharma Corp (ABUS) versus Aon PLC (AON) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Aon PLC (AON) is a insurance brokers company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported AON revenue for 2025-12-31 was $17.18B. Net income was $3.69B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. AON currently screens at market cap $76.61B and trailing P/E 30.7.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. AON currently screens at market cap $76.61B and trailing P/E 30.7.
Not investment advice. Open the ABUS and AON stock pages for the full models.
Not investment advice.